Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China
- PMID: 33750783
- PMCID: PMC7943579
- DOI: 10.1038/s41467-021-21710-6
Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China
Erratum in
-
Author Correction: Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China.Nat Commun. 2021 Apr 8;12(1):2251. doi: 10.1038/s41467-021-22487-4. Nat Commun. 2021. PMID: 33833243 Free PMC article. No abstract available.
-
Author Correction: Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China.Nat Commun. 2021 Apr 30;12(1):2561. doi: 10.1038/s41467-021-23108-w. Nat Commun. 2021. PMID: 33931645 Free PMC article. No abstract available.
Abstract
Several mechanisms driving SARS-CoV-2 transmission remain unclear. Based on individual records of 1178 potential SARS-CoV-2 infectors and their 15,648 contacts in Hunan, China, we estimated key transmission parameters. The mean generation time was estimated to be 5.7 (median: 5.5, IQR: 4.5, 6.8) days, with infectiousness peaking 1.8 days before symptom onset, with 95% of transmission events occurring between 8.8 days before and 9.5 days after symptom onset. Most transmission events occurred during the pre-symptomatic phase (59.2%). SARS-CoV-2 susceptibility to infection increases with age, while transmissibility is not significantly different between age groups and between symptomatic and asymptomatic individuals. Contacts in households and exposure to first-generation cases are associated with higher odds of transmission. Our findings support the hypothesis that children can effectively transmit SARS-CoV-2 and highlight how pre-symptomatic and asymptomatic transmission can hinder control efforts.
Conflict of interest statement
A.V. reports a grant from Metabiota inc., M.A. has received research funding from Seqirus, and H.Y. has received research funding from Sanofi Pasteur, GlaxoSmithKline, Yichang HEC Changjiang Pharmaceutical Company, and Shanghai Roche Pharmaceutical Company. None of those research funding is related to COVID-19. All other authors report no competing interests.
Figures
Update of
-
Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China.medRxiv [Preprint]. 2020 Nov 3:2020.07.23.20160317. doi: 10.1101/2020.07.23.20160317. medRxiv. 2020. Update in: Nat Commun. 2021 Mar 9;12(1):1533. doi: 10.1038/s41467-021-21710-6. PMID: 32793929 Free PMC article. Updated. Preprint.
References
-
- World Health Organization. Coronavirus disease (COVID-19) pandemic. https://www.who.int/emergencies/diseases/novel-%ADcoronavirus-%AD2019 (2020).
-
- World Health Organization. WHO coronavirus disease (COVID-19) dashboard. https://covid19.who.int (2021). - PubMed
-
- United Nations Educational, Scientific and Cultural Organization. Education: from disruption to recovery. https://en.unesco.org/covid19/educationresponse (2020).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
